Vivet Therapeutics raised €45M in a funding round in Jan 2019. The company is based in Paris, France. Investors in the round: Pfizer. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €45M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
